Brain Differences in First-episode Schizophrenia Treated with Quetiapine: a Deformation-based Morphometric Study

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2014 Aug 2

PMID 25080851

Citations 5

Authors

Chunlan Yang

Shuicai Wu

Wangsheng Lu

Yanping Bai

Hongjian Gao

Affiliations

Soon will be listed here.

Abstract

Rationale: With the development of various imaging techniques, the deformation-based morphometry (DBM) method provides an objective automatic examination of the whole brain.

Objectives: This study aims to assess the abnormalities in the brains of first-episode schizophrenia (FES) patients treated with quetiapine using another advanced nonrigid registration method, hierarchical attribute matching mechanism for elastic registration, through the application of DBM in the entire brain.

Methods: Thirty FES patients and 30 normal controls were grouped by age and handedness and subjected to magnetic resonance imaging examination. The patients had relatively short durations of untreated psychosis (DUP; 6.4 ± 5.2 months), and only a single antipsychotic drug, quetiapine (dosage, 200 ± 75 mg), was used for treatment. Statistically significant changes in regional volume were analyzed via DBM. In addition, a voxel-wise analysis of correlations between the duration of treatment or dosage and volume was also performed.

Results: Compared with control subjects, FES patients showed contracted regions located in Brodmann area (BA) 42 and BA 19. By contrast, expanded regions were observed in BA 38, BA 21, BA 6 and 8, and left cerebellum. A negative correlation was observed between dosage and volume in the hippocampus, while a positive correlation was found in the caudate. Meanwhile, a negative correlation was observed between duration of treatment and volume in BA 38.

Conclusion: Both regional volume reductions and increases were detected in the brains of FES patients treated with quetiapine compared with healthy control subjects. Such differences may be partially relevant to dosage and treatment duration in clinic.

Citing Articles

A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-naïve first episode psychosis patients.

Nelson E, Kraguljac N, Bashir A, Cofield S, Maximo J, Armstrong W Mol Psychiatry. 2024; .

PMID: 39580605 DOI: 10.1038/s41380-024-02812-1.

Reduced Hippocampal Subfield Volume in Schizophrenia and Clinical High-Risk State for Psychosis.

Sasabayashi D, Yoshimura R, Takahashi T, Takayanagi Y, Nishiyama S, Higuchi Y Front Psychiatry. 2021; 12:642048.

PMID: 33828496 PMC: 8019805. DOI: 10.3389/fpsyt.2021.642048.

Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment.

Li W, Li K, Guan P, Chen Y, Xiao Y, Lui S Neuroimage Clin. 2018; 20:169-176.

PMID: 30094166 PMC: 6072650. DOI: 10.1016/j.nicl.2018.07.008.

Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis.

Antoniades M, Schoeler T, Radua J, Valli I, Allen P, Kempton M Neurosci Biobehav Rev. 2017; 86:166-175.

PMID: 29223768 PMC: 5818020. DOI: 10.1016/j.neubiorev.2017.12.001.

Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume.

Berk M, Dandash O, Daglas R, Cotton S, Allott K, Fornito A Transl Psychiatry. 2017; 7(1):e1011.

PMID: 28117843 PMC: 5545739. DOI: 10.1038/tp.2016.281.

References

Levitt J, McCarley R, Nestor P, PETRESCU C, Donnino R, Hirayasu Y . Quantitative volumetric MRI study of the cerebellum and vermis in schizophrenia: clinical and cognitive correlates. Am J Psychiatry. 1999; 156(7):1105-7. PMC: 2845842. DOI: 10.1176/ajp.156.7.1105. View

Lewis D, Lieberman J . Catching up on schizophrenia: natural history and neurobiology. Neuron. 2001; 28(2):325-34. DOI: 10.1016/s0896-6273(00)00111-2. View

Wang H, Dunnavant F, Jarman T, Deutch A . Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology. 2004; 29(7):1230-8. DOI: 10.1038/sj.npp.1300449. View

Vita A, De Peri L, Silenzi C, Dieci M . Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res. 2005; 82(1):75-88. DOI: 10.1016/j.schres.2005.11.004. View

Fumagalli F, Molteni R, Bedogni F, Gennarelli M, Perez J, Racagni G . Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801. Neuroreport. 2004; 15(13):2109-12. DOI: 10.1097/00001756-200409150-00022. View

Halim N, Weickert C, McClintock B, Weinberger D, Lipska B . Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology. 2004; 29(6):1063-9. DOI: 10.1038/sj.npp.1300422. View

Tek C, Gold J, Blaxton T, Wilk C, McMahon R, Buchanan R . Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry. 2002; 59(2):146-53. DOI: 10.1001/archpsyc.59.2.146. View

Rimol L, Hartberg C, Nesvag R, Fennema-Notestine C, Hagler Jr D, Pung C . Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry. 2010; 68(1):41-50. DOI: 10.1016/j.biopsych.2010.03.036. View

FABRE Jr L, Arvanitis L, Pultz J, Jones V, Malick J, SLOTNICK V . ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clin Ther. 1995; 17(3):366-78. DOI: 10.1016/0149-2918(95)80102-2. View

10.

Ebdrup B, Skimminge A, Rasmussen H, Aggernaes B, Oranje B, Lublin H . Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol. 2010; 14(1):69-82. DOI: 10.1017/S1461145710000817. View

11.

Shen D, Davatzikos C . HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging. 2003; 21(11):1421-39. DOI: 10.1109/TMI.2002.803111. View

12.

LEVITT J, Blanton R, Caplan R, Asarnow R, GUTHRIE D, Toga A . Medial temporal lobe in childhood-onset schizophrenia. Psychiatry Res. 2001; 108(1):17-27. DOI: 10.1016/s0925-4927(01)00108-1. View

13.

Purdon S, Malla A, LABELLE A, Lit W . Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci. 2001; 26(2):137-49. PMC: 1407745. View

14.

Mitelman S, Shihabuddin L, Brickman A, Hazlett E, Buchsbaum M . MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry. 2003; 160(12):2154-68. DOI: 10.1176/appi.ajp.160.12.2154. View

15.

Whitwell J . Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J Neurosci. 2009; 29(31):9661-4. PMC: 6666603. DOI: 10.1523/JNEUROSCI.2160-09.2009. View

16.

Taylor J, Blanton R, Levitt J, Caplan R, Nobel D, Toga A . Superior temporal gyrus differences in childhood-onset schizophrenia. Schizophr Res. 2005; 73(2-3):235-41. DOI: 10.1016/j.schres.2004.07.023. View

17.

Tarazi F, Zhang K, Baldessarini R . Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther. 2001; 297(2):711-7. View

18.

Whitford T, Grieve S, Farrow T, Gomes L, Brennan J, Harris A . Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage. 2006; 32(2):511-9. DOI: 10.1016/j.neuroimage.2006.03.041. View

19.

Small J, Hirsch S, Arvanitis L, Miller B, Link C . Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry. 1997; 54(6):549-57. DOI: 10.1001/archpsyc.1997.01830180067009. View

20.

Ebdrup B, Glenthoj B, Rasmussen H, Aggernaes B, Langkilde A, Paulson O . Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia. J Psychiatry Neurosci. 2010; 35(2):95-104. PMC: 2834791. DOI: 10.1503/jpn.090049. View